Sisram MedicalSRAMF 60 PB Ratio is 0.43 as of Jun. 27, 2026, which is 46% below its 10-year median of 0.79. GuruFocus rates SRAMF with a GF Score™ of 60/100 and a GF Value™ of $0.95 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Sisram Medical ranks better than 97.97% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-27), Sisram Medical's share price is $0.43835. Sisram Medical's Book Value per Share for the quarter that ended in Dec. 2025 was $1.03. Hence, Sisram Medical's PB Ratio of today is 0.43.
Good Sign:
Sisram Medical Ltd stock PB Ratio (=0.28) is close to 10-year low of 0.28.
The historical rank and industry rank for Sisram Medical's PB Ratio or its related term are showing as below:
SRAMF'
s PB Ratio Range Over the Past 10 Years
Min: 0.28 Med: 0.79 Max: 11.49
Current: 0.28
During the past 12 years, Sisram Medical's highest PB Ratio was 11.49. The lowest was 0.28. And the median was 0.79.
SRAMF's PB Ratio is ranked better than 97.97% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.02
vs SRAMF: 0.28
During the past 12 months, Sisram Medical's average Book Value Per Share Growth Rate was 3.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 3.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 6.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 24.00% per year.
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Sisram Medical was 120.60% per year. The lowest was 3.60% per year. And the median was 7.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Sisram Medical PB Ratio Related Terms
Sisram Medical PB Ratio Historical Data
* Premium members only.
The historical data trend for Sisram Medical's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sisram Medical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sisram Medical PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's PB Ratio distribution charts can be found below:
* The bar in red indicates where Sisram Medical's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Sisram Medical's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Sisram Medical (SRAMF) has a PB Ratio of 0.43 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sisram Medical and its competitors. This is 46% below median its historical median of 0.79. Over the past decade, Sisram Medical's PB Ratio has ranged from 0.28 to 11.49. According to the industry distribution chart, Sisram Medical ranks #16 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 2%.
Is Sisram Medical's PB Ratio too high?
Sisram Medical's current PB Ratio of 0.43 is 46% below median its 10-year median of 0.79. Over the past 10 years, this metric has ranged from a low of 0.28 to a high of 11.49. The Medical Devices & Instruments industry median PB Ratio is 2.02. Sisram Medical's value of 0.43 is 78.7% below this industry median. Based on the distribution chart, Sisram Medical ranks #16 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sisram Medical has a GF Score™ of 60/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sisram Medical's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sisram Medical ranks #16 out of 788 companies for PB Ratio. This places Sisram Medical in the top 2% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.02. Sisram Medical's value of 0.43 is 78.7% below this benchmark. Historically, Sisram Medical's own PB Ratio has ranged from 0.28 to 11.49 over the past decade. While the company's 10-year median is 0.79 vs. the industry median of 2.02, Sisram Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sisram Medical's current PB Ratio of 0.43 is 78.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sisram Medical and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sisram Medical's current PB Ratio is 0.43, which is 46% below median its own 10-year median of 0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sisram Medical stock overvalued right now?
Based on GuruFocus' analysis, Sisram Medical (SRAMF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.95, compared to a current price of $0.44 — trading 53.9% below its estimated fair value. The current PB Ratio is 0.43, which is 46% below median its 10-year median of 0.79 and 78.7% below the Medical Devices & Instruments industry median of 2.02. Sisram Medical's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Sisram Medical (SRAMF), the current PB Ratio is 0.43 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sisram Medical (SRAMF) Overvalued in 2026?
Based on GuruFocus' analysis, Sisram Medical stock appears to be undervalued.
The current stock price of $0.44 is trading 53.9% below its estimated GF Value™ of $0.95.
GuruFocus considers Sisram Medical to be Significantly Undervalued.
Key valuation signals for SRAMF:
PB Ratio: 0.43 (46% below median its 10-year median of 0.79)
GF Value™: $0.95 vs. price of $0.44 (53.9% below fair value)
Industry Position: 78.7% below the Medical Devices & Instruments median (#16 of 788)
No single metric tells the full story. See the SRAMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The Company is involved in research, development, design, manufacture, sale and marketing of medical aesthetics and dental equipment, home use devices, injectables and cosmeceuticals products. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
60GF Score
Get the complete analysis for SRAMF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRAMF has been successfully added to your 
